Drug Profile
Research programme: antivirals - Gilead Sciences
Alternative Names: Acyclic nucleoside phosphonates - Gilead Sciences; GS 327073; GS 8374; GS 9224; N4-acyl derivatives of cidofovir - GileadLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Gilead Sciences; Institute of Organic Chemistry and Biochemistry (Prague); Rega Institute for Medical Research
- Class Nucleotides; Small molecules
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors; HIV integrase inhibitors; HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in Europe
- 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in USA
- 03 May 2007 Preclinical trials in Viral infections in Europe (unspecified route)